The Impact of Telemedicine-Augmented Integrated Personalized Diabetes Management on Glycemic Control in Adults With Diabetes Mellitus During the COVID-19 Pandemic: A Retrospective Study

Abstract

Get full access to this article

View all access options for this article.

References

de Kreutzenberg

. Telemedicine for the clinical management of diabetes: implications and considerations after COVID-19 experience. High Blood Press Cardiovasc Prev. 2022;29(4):319-326.

Crossen

Bruggeman

Haller

Raymond

. Challenges and opportunities in using telehealth for diabetes care. Diabetes Spectr. 2022;35(1):33-42.

Lee

SWH

Chan

CKY

Chua

Chaiyakunapruk

. Comparative effectiveness of telemedicine strategies on type 2 diabetes management: a systematic review and network meta-analysis. Sci Rep. 2017;7(1):12680.

Lee

SWH

Ooi

Lai

. Telemedicine for the management of glycemic control and clinical outcomes of Type 1 diabetes mellitus: a systematic review and meta-analysis of randomized controlled studies. Front Pharmacol. 2017;8:330.

Kulzer

Daenschel

, et al. Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: results of the PDM-ProValue study program. Diabetes Res Clin Pract. 2018;144:200-212.

Porntharukchareon

Worawichawong

Tawinprai

. Telehealth for diabetes care during coronavirus disease 2019 pandemic. Asia Pac J Public Health. 2022;34(4):459-462.

Areevut

Sakmanarit

Tachanivate

, et al. Noninferiority of telemedicine delivered compared with in-person Diabetes Self-Management Education and Support (DSMES) during Covid-19 pandemic in Thailand. Asia Pac J Public Health. 2022;34(8):799-803.

Draznin

Aroda

Bakris

, et al. 6. Glycemic targets: Standards of Medical Care in Diabetes—2022. Diabetes Care. 2022;45(suppl 1):S83-S96.

LeRoith

Biessels

Braithwaite

, et al. Treatment of diabetes in older adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2019;104(5):1520-1574.